ArticleOphthalmology and therapy2026

Head-to-Head Comparison of an IGF-1R Inhibitor Versus Intravenous Glucocorticoid for Active Thyroid Eye Disease: Design of a Randomized Clinical Trial.

Haiyang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.